Triple-negative breast cancer: promising prognostic biomarkers currently in developmentJasmine Sukumar, Nicole Williams, Maryam B. Lustberg et al.|Expert Review of Anticancer Therapy|2020Cited by 236
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerSagar Sardesai, Bhuvaneswari Ramaswamy, Evan Morgan et al.|Cardio-Oncology|2020Cited by 32
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancerJasmine Sukumar, Sagar Sardesai, Dionisia Quiroga et al.|Breast Cancer Research and Treatment|2021Cited by 18
Chronic chemotherapy-induced peripheral neuropathy: living with neuropathy during and after cancer treatmentsNur Rahman, Maryam B. Lustberg, Jasmine Sukumar|Annals of Palliative Medicine|2025Cited by 16
Delay Discounting as a Potential Therapeutic Target for Weight Loss in Breast Cancer SurvivorsJasmine Sukumar, Jeffrey S. Stein, Sagar Sardesai et al.|Cancers|2022Cited by 12